IHH Healthcare is seeking compensation of up to $1.7b (₹109.3b) from Japanese drugmaker Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.
Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback